123 related articles for article (PubMed ID: 31008451)
1. A review of adherence to the Mediterranean diet and breast cancer risk according to estrogen- and progesterone-receptor status and HER2 oncogene expression.
Coughlin SS; Stewart J; Williams LB
Ann Epidemiol Public Health; 2018; 1():. PubMed ID: 31008451
[TBL] [Abstract][Full Text] [Related]
2. Adherence to the Vegetable-Fruit-Soy Dietary Pattern, a Reference From Mediterranean Diet, Protects Against Postmenopausal Breast Cancer Among Chinese Women.
Cao S; Liu L; Zhu Q; Zhu Z; Zhou J; Wei P; Wu M
Front Nutr; 2022; 9():800996. PubMed ID: 35425800
[TBL] [Abstract][Full Text] [Related]
3. Adherence to the Western, Prudent and Mediterranean dietary patterns and breast cancer risk: MCC-Spain study.
Castelló A; Boldo E; Pérez-Gómez B; Lope V; Altzibar JM; Martín V; Castaño-Vinyals G; Guevara M; Dierssen-Sotos T; Tardón A; Moreno V; Puig-Vives M; Llorens-Ivorra C; Alguacil J; Gómez-Acebo I; Castilla J; Gràcia-Lavedán E; Dávila-Batista V; Kogevinas M; Aragonés N; Amiano P; Pollán M
Maturitas; 2017 Sep; 103():8-15. PubMed ID: 28778338
[TBL] [Abstract][Full Text] [Related]
4. Mediterranean diet adherence and risk of postmenopausal breast cancer: results of a cohort study and meta-analysis.
van den Brandt PA; Schulpen M
Int J Cancer; 2017 May; 140(10):2220-2231. PubMed ID: 28260236
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004.
Parise CA; Bauer KR; Brown MM; Caggiano V
Breast J; 2009; 15(6):593-602. PubMed ID: 19764994
[TBL] [Abstract][Full Text] [Related]
6. Associations between Diet Quality Scores and Risk of Postmenopausal Estrogen Receptor-Negative Breast Cancer: A Systematic Review.
Du M; Liu SH; Mitchell C; Fung TT
J Nutr; 2018 Jan; 148(1):100-108. PubMed ID: 29378048
[TBL] [Abstract][Full Text] [Related]
7. Relationship of established risk factors with breast cancer subtypes.
McCarthy AM; Friebel-Klingner T; Ehsan S; He W; Welch M; Chen J; Kontos D; Domchek SM; Conant EF; Semine A; Hughes K; Bardia A; Lehman C; Armstrong K
Cancer Med; 2021 Sep; 10(18):6456-6467. PubMed ID: 34464510
[TBL] [Abstract][Full Text] [Related]
8. Risk of mortality of node-negative, ER/PR/HER2 breast cancer subtypes in T1, T2, and T3 tumors.
Parise CA; Caggiano V
Breast Cancer Res Treat; 2017 Oct; 165(3):743-750. PubMed ID: 28689363
[TBL] [Abstract][Full Text] [Related]
9. Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences study.
Ma H; Wang Y; Sullivan-Halley J; Weiss L; Marchbanks PA; Spirtas R; Ursin G; Burkman RT; Simon MS; Malone KE; Strom BL; McDonald JA; Press MF; Bernstein L
Cancer Res; 2010 Jan; 70(2):575-87. PubMed ID: 20068186
[TBL] [Abstract][Full Text] [Related]
10. Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.
Ellingjord-Dale M; Vos L; Tretli S; Hofvind S; Dos-Santos-Silva I; Ursin G
Breast Cancer Res; 2017 Jan; 19(1):10. PubMed ID: 28114999
[TBL] [Abstract][Full Text] [Related]
11. Breastfeeding and breast cancer risk by receptor status--a systematic review and meta-analysis.
Islami F; Liu Y; Jemal A; Zhou J; Weiderpass E; Colditz G; Boffetta P; Weiss M
Ann Oncol; 2015 Dec; 26(12):2398-407. PubMed ID: 26504151
[TBL] [Abstract][Full Text] [Related]
12. Spanish Mediterranean diet and other dietary patterns and breast cancer risk: case-control EpiGEICAM study.
Castelló A; Pollán M; Buijsse B; Ruiz A; Casas AM; Baena-Cañada JM; Lope V; Antolín S; Ramos M; Muñoz M; Lluch A; de Juan-Ferré A; Jara C; Jimeno MA; Rosado P; Díaz E; Guillem V; Carrasco E; Pérez-Gómez B; Vioque J; Boeing H; Martín M;
Br J Cancer; 2014 Sep; 111(7):1454-62. PubMed ID: 25101568
[TBL] [Abstract][Full Text] [Related]
13. Dietary fiber intake and risk of postmenopausal breast cancer defined by estrogen and progesterone receptor status--a prospective cohort study among Swedish women.
Suzuki R; Rylander-Rudqvist T; Ye W; Saji S; Adlercreutz H; Wolk A
Int J Cancer; 2008 Jan; 122(2):403-12. PubMed ID: 17764112
[TBL] [Abstract][Full Text] [Related]
14. Adherence to the mediterranean diet and risk of breast cancer in the European prospective investigation into cancer and nutrition cohort study.
Buckland G; Travier N; Cottet V; González CA; Luján-Barroso L; Agudo A; Trichopoulou A; Lagiou P; Trichopoulos D; Peeters PH; May A; Bueno-de-Mesquita HB; Bvan Duijnhoven FJ; Key TJ; Allen N; Khaw KT; Wareham N; Romieu I; McCormack V; Boutron-Ruault M; Clavel-Chapelon F; Panico S; Agnoli C; Palli D; Tumino R; Vineis P; Amiano P; Barricarte A; Rodríguez L; Sanchez MJ; Chirlaque MD; Kaaks R; Teucher B; Boeing H; Bergmann MM; Overvad K; Dahm CC; Tjønneland A; Olsen A; Manjer J; Wirfält E; Hallmans G; Johansson I; Lund E; Hjartåker A; Skeie G; Vergnaud AC; Norat T; Romaguera D; Riboli E
Int J Cancer; 2013 Jun; 132(12):2918-27. PubMed ID: 23180513
[TBL] [Abstract][Full Text] [Related]
15. Healthy dietary patterns and risk of breast cancer by molecular subtype.
Hirko KA; Willett WC; Hankinson SE; Rosner BA; Beck AH; Tamimi RM; Eliassen AH
Breast Cancer Res Treat; 2016 Feb; 155(3):579-88. PubMed ID: 26872903
[TBL] [Abstract][Full Text] [Related]
16. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
17. Breast Cancer Survival Analysis Based on Immunohistochemistry Subtypes (ER/PR/HER2): a Retrospective Cohort Study.
Poorolajal J; Nafissi N; Akbari ME; Mahjub H; Esmailnasab N; Babaee E
Arch Iran Med; 2016 Oct; 19(10):680-686. PubMed ID: 27743431
[TBL] [Abstract][Full Text] [Related]
18. Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study.
Ritte R; Lukanova A; Berrino F; Dossus L; Tjønneland A; Olsen A; Overvad TF; Overvad K; Clavel-Chapelon F; Fournier A; Fagherazzi G; Rohrmann S; Teucher B; Boeing H; Aleksandrova K; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Sieri S; Panico S; Tumino R; Vineis P; Quirós JR; Buckland G; Sánchez MJ; Amiano P; Chirlaque MD; Ardanaz E; Sund M; Lenner P; Bueno-de-Mesquita B; van Gils CH; Peeters PH; Krum-Hansen S; Gram IT; Lund E; Khaw KT; Wareham N; Allen NE; Key TJ; Romieu I; Rinaldi S; Siddiq A; Cox D; Riboli E; Kaaks R
Breast Cancer Res; 2012 May; 14(3):R76. PubMed ID: 22583394
[TBL] [Abstract][Full Text] [Related]
19. Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study.
Suzuki R; Ye W; Rylander-Rudqvist T; Saji S; Colditz GA; Wolk A
J Natl Cancer Inst; 2005 Nov; 97(21):1601-8. PubMed ID: 16264180
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
